What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer

OBJECTIVE. Patients with advanced epithelial ovarian cancer (EOC) alive without progression at a landmark time-point of 10 years from diagnosis are likely cured. We report the proportion of patients with Stage III EOC who were long-term disease-free survivors (LTDFS≥10 years) following either intrap...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitiyarachchi, Omali, Friedlander, Michael, Java, James J., Chan, John K., Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas J., Monk, Bradley J., Backes, Floor, Alvarez Secord, Angeles, Bonebrake, Albert, Rose, Peter G., Tewari, Krishnansu S., Lentz, Samuel S., Geller, Melissa A., Copeland, Larry J., Mannel, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718158/
https://www.ncbi.nlm.nih.gov/pubmed/35835612
http://dx.doi.org/10.1016/j.ygyno.2022.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718158/
https://www.ncbi.nlm.nih.gov/pubmed/35835612
http://dx.doi.org/10.1016/j.ygyno.2022.07.004

Ejemplares similares